SCHEMBL9867265

SCHEMBL9867265

NCCSCc1ccc2ccccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB5 P28074 1/20 0.44
▸ CYSLTR2 Q9NS75 1/20 0.44
▸ CYSLTR1 Q9Y271 1/20 0.44
▸ CYP1A2 P05177 5/20 0.42
▸ CYP2D6 P10635 4/20 0.42
▸ CYP2C19 P33261 4/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ CYP2C9 P11712 3/20 0.42
▸ NCF1 P14598 1/20 0.41
▸ NOS2 P35228 1/20 0.41
▸ BACE1 P56817 1/20 0.41
▸ CYP2E1 P05181 1/20 0.41
▸ CYP2C8 P10632 1/20 0.41
▸ CYP2B6 P20813 1/20 0.41
▸ PRNP P04156 2/20 0.40
▸ RXFP1 Q9HBX9 2/20 0.40
▸ MAPK10 P53779 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.39
▸ DDAH1 O94760 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2877991 0.85 CYSLTR1 (0.52) PSMB5CYSLTR2CYSLTR1CYP1A2NCF1
SCHEMBL11180126 0.80 CYSLTR1 (0.45) PSMB5CYSLTR2CYSLTR1CYP1A2PRNP
SCHEMBL5594071 0.79 CYSLTR1 (0.46) PSMB5CYSLTR2CYSLTR1CYP1A2CYP2D6
SCHEMBL11189914 0.76 PSMB5 (0.51) PSMB5CYSLTR2CYSLTR1CYP1A2PRNP
SCHEMBL30285321 0.76 PDE10A (0.50) CYSLTR2CYSLTR1CYP1A2CYP2D6CYP2C19
SCHEMBL2305245 0.76 PDE10A (0.50) CYSLTR2CYSLTR1CYP1A2CYP2D6CYP2C19
SCHEMBL29899422 0.75 CYSLTR1 (0.53) CYSLTR2CYSLTR1CYP1A2CYP3A4NCF1
SCHEMBL506666 0.75 CYSLTR1 (0.53) CYSLTR2CYSLTR1CYP1A2CYP3A4NCF1
SCHEMBL12795599 0.75 PRNP (0.61) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL23844622 0.74 CYP1A2 (0.52) CYSLTR2CYSLTR1CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 — — US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 — — EP disclosed
US-4634701-A Furan derivatives having anti-ulcer activity AUSONIA FARMACEUTICI S.R.L. (IT) 1987-01-06 — — US disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 — — EP disclosed
EP-0164040-A2 Furan derivatives having anti-ulcer activity AUSONIA FARMACEUTICI S.r.l. (IT) 1985-12-11 — — EP disclosed
Send feedback